Stem cells aim to rescue lungs in Life-Threatening ARDS trial
NCT ID NCT07479043
First seen Mar 23, 2026 · Last updated May 13, 2026 · Updated 9 times
Summary
This study tests a new stem cell therapy called JadiCell for people with acute respiratory distress syndrome (ARDS), a severe lung condition. The treatment is given through a vein and is designed to calm inflammation and help lung tissue heal. The trial will include 128 hospitalized adults and will measure how many patients survive without needing a breathing machine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.